Apple to Turn to Intel for Cellular Modems, Over Qualcomm
Apple will be using Intel as its supplier for cellular modems for iPhones iterated in 2018.
The announcement of Apple’s new reliance on Intel is expected to eliminate the company’s longstanding reliance on Qualcomm modems for the iPhone. This decision of Apple is said to have been a result of the disputed between Apple and Qualcomm. A lawsuit between the two companies, alleges that Apple inopportunely shared copyrighted code with Intel.
The forthcoming exclusivity of Intel’s might be short-lived, as it could be possible that Apple could still intend working with Qualcomm, by drawing to a negotiating concession ending the legal quarrel. Apple has been famous for relying on any individual supplier too heavily and so does its history show a diversified supply chain for displays and other components. The company also prefers building its own parts such as its recent effort to make its own GPU.
The future of iPhone has not been predicted in clear terms, as customers would most probably anticipate faster LTE in the next iPhone, whether the chip supplier is Intel or Qualcomm. This is the foreseeable next step the company will be making so as to keep pace with the upcoming Galaxy S9 and its Exynos 9 chip, which also promises accelerated cellular connectivity.
You may be interested
Gastrointestinal Devices Market Analysis & Outlook 2018-2026 | Top Players are Boston Scientific Corporation, Johnson & Johnson Ltd., Covidien Ltd., Fujinon Ltd., Stryker CorporationAlbert R - November 16, 2018
All bilaterians (animals having a bilateral symmetry) have a GI tract. Primarily, it is a tube that can transfer food to various organs of digestion. In case…
Opioids Market Growth Analysis By Top Players Purdue Pharma L.P., Janssen Pharmaceuticals, Inc., West – Ward Pharmaceuticals Corporation, Pfizer, Inc., Egalet Corporation, Allergan plc, Sanofi SA, Boehringer Ingelheim, and Sun Pharmaceutical Industries Ltd.Albert R - November 16, 2018
According to the American Academy of Pain Medicine (2011), the number of people who suffered from chronic pain was around 1.8 billion. Moreover, according to the NIH…
Bone Cancer Treatment Market Industry Growth Analysis Top Players Amgen Inc., Actavis plc, Novartis International AG, Debiopharm Group, Pfizer, Inc., and Eli Lilly and Company.Albert R - November 16, 2018
The bone cancer treatment market is analyzed on the basis of type of bone cancer into primary bone cancer and secondary bone cancer. Primary bone cancer originates…